Sai Life Sciences Q2 FY27 Profit Jumps 17% To ₹98 Crore, Revenue Surges 23% As Company Invests ₹621 Crore In Expansion
Sai Life Sciences recorded strong topline growth during Q2 FY27, with revenue increasing by ₹122 crore over the year-ago quarter. The performance reflected continued business momentum across the company's pharmaceutical services operations. Earnings before interest, taxes, depreciation and amortisation (EBITDA) increased 20 per cent…